Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pentoxifylline on Diabetic Neuropathy in Patients with Type 2 Diabetes
IRCT2016051827965N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Tehran University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM), sponsored by Vice Chancellor for Research of Tehran University of Medical Sciences. Started Mar 2016; status: completed.
02
Drugs
pentoxifylline
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT2016051827965N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016051827965N1.